Find Clinical Trial

A study to assess the release profiles from fixed combination tablets (gliclazide MR/metformin)


← Back
Study Phase Phase 1
Therapeutic Area Metabolism
Active Substance GLICLAZIDEGLICLAZIDE - METFORMINE - S005720METFORMINES005720
SponsorInstitut de Recherches Internationales Servier (I.R.I.S)
Active Substance CodeS005720
Protocol CodePKH-05720-001
EudraCT Code
ISRCTN CodeISRCTN41840459


Documents and links

Results summary READ MORE




Servier Glossary of Terms

To ease the reading, we are developing a glossary of terms. In this glossary, we provide the lay terms used in our lay summaries and the corresponding medical terms. You will find the Servier Glossary of Terms on this link.



© 2017 LES LABORATOIRES SERVIER, an incorporated company of Servier.
All Rights Reserved. Servier does not sell its products over the Internet.
More information

Report a side-effect with a drug.